LEGACY FACILITY: DECISION MAKING ANALYSIS CASE STUDY OF PT BIO FARMA
Biofarma has facing the issue of legacy facility that become findings in routine inspection of NRA. The issue can be escalated to shutdown the production facility due to legacy facility hardly comply with cGMP. The study is for choose the best alternatives of build new facility, renovating current f...
Saved in:
Main Author: | |
---|---|
Format: | Theses |
Language: | Indonesia |
Subjects: | |
Online Access: | https://digilib.itb.ac.id/gdl/view/75751 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
id |
id-itb.:75751 |
---|---|
spelling |
id-itb.:757512023-08-07T14:22:08ZLEGACY FACILITY: DECISION MAKING ANALYSIS CASE STUDY OF PT BIO FARMA Satrio Wicaksono, Muhammad Manajemen umum Indonesia Theses Legacy Facility, cGMP, MCDM, AHP. INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/75751 Biofarma has facing the issue of legacy facility that become findings in routine inspection of NRA. The issue can be escalated to shutdown the production facility due to legacy facility hardly comply with cGMP. The study is for choose the best alternatives of build new facility, renovating current facility and toll manufacturing with consideration of financial, regulation compliance, project completion speed and strategy risk. The study is using Analytic Hierarchy Process (AHP) to get a decision from the experts in biofarma. the respondents are 7 people with many expertise including finance, project management, GMP, Operations, Demand Forecasting, Tech. Transfer, Business Development, cGMP engineering and the management representative. To get conclusion of group decision making, the results of each respondent is being aggregated with geometric mean. The compliance with regulation (0.356) become the top priority, followed by strategy risk (0.295), project completion speed (0.250) and financial aspect (0.098). The findings is build new facility (0.4563) is become the best alternative among the other alternatives followed by toll manufacturing (0.3251) and renovating current facility (0.2186). The finding is build new facility is become the best alternative among the other alternatives (0.4563) followed by toll manufacturing (0.3251) and renovating current facility (0.2186) with considering of criteria financial aspect, regulation aspect, project completion speed aspect and strategy risk aspect. The recommendation is for build new facility the project plan should be implemented. text |
institution |
Institut Teknologi Bandung |
building |
Institut Teknologi Bandung Library |
continent |
Asia |
country |
Indonesia Indonesia |
content_provider |
Institut Teknologi Bandung |
collection |
Digital ITB |
language |
Indonesia |
topic |
Manajemen umum |
spellingShingle |
Manajemen umum Satrio Wicaksono, Muhammad LEGACY FACILITY: DECISION MAKING ANALYSIS CASE STUDY OF PT BIO FARMA |
description |
Biofarma has facing the issue of legacy facility that become findings in routine inspection of NRA. The issue can be escalated to shutdown the production facility due to legacy facility hardly comply with cGMP. The study is for choose the best alternatives of build new facility, renovating current facility and toll manufacturing with consideration of financial, regulation compliance, project completion speed and strategy risk. The study is using Analytic Hierarchy Process (AHP) to get a decision from the experts in biofarma. the respondents are 7 people with many expertise including finance, project management, GMP, Operations, Demand Forecasting, Tech. Transfer, Business Development, cGMP engineering and the management representative. To get conclusion of group decision making, the results of each respondent is being aggregated with geometric mean. The compliance with regulation (0.356) become the top priority, followed by strategy risk (0.295), project completion speed (0.250) and financial aspect (0.098). The findings is build new facility (0.4563) is become the best alternative among the other alternatives followed by toll manufacturing (0.3251) and renovating current facility (0.2186). The finding is build new facility is become the best alternative among the other alternatives (0.4563) followed by toll manufacturing (0.3251) and renovating current facility (0.2186) with considering of criteria financial aspect, regulation aspect, project completion speed aspect and strategy risk aspect. The recommendation is for build new facility the project plan should be implemented. |
format |
Theses |
author |
Satrio Wicaksono, Muhammad |
author_facet |
Satrio Wicaksono, Muhammad |
author_sort |
Satrio Wicaksono, Muhammad |
title |
LEGACY FACILITY: DECISION MAKING ANALYSIS CASE STUDY OF PT BIO FARMA |
title_short |
LEGACY FACILITY: DECISION MAKING ANALYSIS CASE STUDY OF PT BIO FARMA |
title_full |
LEGACY FACILITY: DECISION MAKING ANALYSIS CASE STUDY OF PT BIO FARMA |
title_fullStr |
LEGACY FACILITY: DECISION MAKING ANALYSIS CASE STUDY OF PT BIO FARMA |
title_full_unstemmed |
LEGACY FACILITY: DECISION MAKING ANALYSIS CASE STUDY OF PT BIO FARMA |
title_sort |
legacy facility: decision making analysis case study of pt bio farma |
url |
https://digilib.itb.ac.id/gdl/view/75751 |
_version_ |
1822007778127904768 |